| Name | Title | Contact Details |
|---|---|---|
Scott Seligman |
Chief Technology Officer | Profile |
Melior Discovery Inc (Exton, PA, USA) has pioneered a unique high throughput in vivo pharmacology platform (theraTRACE®) able to systematically identify novel indications for pre-clinical and development stage drugs. theraTRACE® is widely used by both multinational pharmaceutical and start-up biopharmaceutical companies alike to fully explore the therapeutic potential of their drug candidates. Melior has also leveraged this expertise to build a high quality, onshore, preclinical services capability offering in vivo efficacy models in a broad range of therapeutic areas, pharmacokinetic evaluations, specialized animal models and bioanalytical services to drug developers worldwide.
Signature Pharmacy is a Winter Park, FL-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
3129 Sanofi SA is a French multinational healthcare company headquartered in Paris, France.
Health Network is a Cranston, RI-based company in the Healthcare, Pharmaceuticals, and Biotech sector.